Premium
Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus–infected patients with mixed cryoglobulinemia
Author(s) -
Sansonno Domenico,
Cornacchiulo Vito,
Iacobelli Anna Rina,
Di Stefano Rita,
Lospalluti Mario,
Dammacco Franco
Publication year - 1995
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.1840210207
Subject(s) - hepatitis c virus , cryoglobulinemia , pathology , hepatitis c , immunohistochemistry , medicine , antigen , liver biopsy , biopsy , antibody , virology , virus , immunology
Skin and/or liver biopsy specimens were obtained from the following patients: 15 anti–hepatitis C virus (HCV), HCV RNA–positive patients and 3 anti‐HCV, HCV RNA–negative patients with type II mixed cryoglobulinemia (MC); 7 anti‐HCV, HCV RNA–positive patients with chronic active liver disease (CALD); 5 anti‐HCV, HCV RNA–negative patients with noncryoglobulinemic vasculitis; and 7 anti‐HCV, HCV RNA–negative patients with lichen ruber planus. A pool of murine monoclonal antibodies (MAbs) developed against c22‐3, c33c, and c100‐3 proteins was used to detect HCV‐related antigens (Ags) by indirect immunohistochemistry. Acid electroelution (AEE) of tissue sections was performed to enhance the sensitivity of the immunohistochemical method. In anti‐HCV–positive MC patients, specific HCV‐related Ags were detected in the small vessels of the skin and in the cytoplasm of hepatocytes. Prior AEE of biopsy sections allowed detection of HCV Age in 6 of 15 (40%) skin biopsy and in 9 of 14 (64.3%) liver biopsy specimens. HCV immunoreactive deposits in the skin displayed two immunohistochemical patterns: (1) coarse intraluminal material associated with dermal inflammatory infiltrates and intravascular deposition of eosinophilic hyaline material; and (2) reactivity confined to the vessel wall in the context of an apparently normal tissue. Immunoglobulin (Ig) G and IgM deposition in the skin showed immunohistochemical features comparable with those found for HCV Ag deposits. In addition, tissue complement reactivity was detected in 6 (40%) of them and was strictly associated with histological and clinical signs of active vasculities. Five of 7 (71.4%) liver biopsy specimens, but none of 7 skin biopsy specimens, from anti‐HCV, HCV RNA–positive patients without circulating cryoglobulins displayed immune reactivity after AEE procedure. Consistently negative results were obtained with skin and liver sections from all anti‐HCV, HCV RNA–negative patients. These findings indicate that, under the experimental conditions used, in 40% of anti‐HCV, HCV RNA–positive patients with MC, skin tissue deposits consist of HCV‐containing immune complexes. In addition, the occurrence of HCV reactivity in apparently normal blood vessels suggests that deposition of viral Ags precedes and possibly initiates tissue damage. Whether in the remaining patients HCV Ags cannot be detected because of the insufficient sensitivity of the method or the involvement of Ags other than those assayed, remains to be determined. (H EPATOLOGY 1995;21:305–312.)